ACUTE MYELOGENOUS LEUKEMIA
Clinical trials for ACUTE MYELOGENOUS LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOGENOUS LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE MYELOGENOUS LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood cancer transplant study tests two conditioning regimens
Disease control TerminatedThis study looked at adults with certain blood cancers (like leukemia) who were getting a stem cell transplant. It compared two different chemotherapy combinations given before the transplant to see which one better prevented the cancer from coming back within a year. The study w…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE3 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis early-stage trial tested a new drug called gentulizumab in 58 people with advanced acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that had not responded to other treatments. The drug aims to help the immune system attack cancer cells by blocking a protein cal…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC